Proteomic biomarkers, pathway analysis and associations with declining cognitive performance in patients hospitalized for acute heart failure

The heart and the brain are often treated as separate organs, each with its own specialists and its own set of diseases. Yet, in the reality of human health, they are deeply intertwined. When the heart struggles to pump blood effectively, a condition known as heart failure, the consequences ripple far beyond the chest. One of the most common and troubling side effects is a decline in mental sharpness. Patients often find their memory, attention, and ability to plan tasks slipping away. This is not merely a matter of feeling tired; it is a measurable impairment that makes it harder for patients to manage their own care, follow medical advice, and stay independent. Scientists have long suspected that the same biological forces damaging the heart are also harming the brain, but the specific chemical signals linking the two have remained a mystery. Uncovering these signals is crucial, because understanding the root cause is the first step toward developing treatments that could protect both the heart and the mind.

In a recent study focused on patients hospitalized for acute heart failure, researchers set out to find these hidden chemical links. They worked with a group of 182 individuals, mostly men with an average age of 75, who had been admitted to a hospital in Sweden for heart failure. The team wanted to see if specific proteins circulating in the blood could explain why some patients had better mental function than others. To do this, they first assessed the patients' cognitive abilities using three standard tests. One test measured overall mental function, another checked how quickly a person could connect dots to show their attention and visual skills, and a third evaluated how fast they could process information and switch between tasks. At the same time, the researchers analyzed blood samples to measure the levels of 92 different proteins. These proteins were chosen because they are known to be involved in inflammation, the immune system, and heart disease.

The researchers looked for patterns between the protein levels and the test scores, carefully adjusting their analysis to account for factors that could skew the results, such as age, sex, education level, and other health conditions like diabetes or high blood pressure. Their search yielded a clear result: 17 specific proteins were consistently associated with poorer performance across all three cognitive tests. In other words, higher levels of these proteins in the blood correlated with lower scores on the mental tests. When the researchers applied stricter clinical cut-offs to define what counts as cognitive impairment, five of these proteins stood out as being strongly linked to the presence of impairment. These five were EPHB4, IL2-RA, LTBR, TLT-2, and COL1A1.

To understand what these proteins might be doing, the team examined the biological pathways they belong to. They found that the proteins clustered around three main themes. The first theme involved how cells stick to one another and communicate through structures called integrins. The second theme centered on the breakdown and remodeling of the extracellular matrix, which is the scaffolding that holds cells together in tissues. The third theme related to how cells sense and respond to physical pressure or mechanical load. These findings suggest that the connection between heart failure and cognitive decline may not be just about a lack of blood flow, but rather a complex process involving inflammation and the structural remodeling of tissues.

One protein in particular, COL1A1, showed the strongest association with cognitive decline. This protein is a major building block of the extracellular matrix, the structural framework of our tissues. While scientists already knew that COL1A1 plays a role in heart failure and tissue scarring, this study is the first to link it directly to cognitive impairment in heart failure patients. Another protein, Osteopontin, was also highlighted; it has previously been linked to inflammation in the brain in models of Alzheimer's disease. The study suggests that the same inflammatory processes that cause the heart to stiffen and remodel might be damaging the brain's structural integrity and its ability to process information.

The researchers were careful to note the limits of their work. Because the study looked at patients at a single point in time, it cannot prove that these proteins cause the cognitive decline; it only shows they are present together. The group of patients was also mostly older and of European descent, which means the results might look different in other populations. Additionally, the study did not account for temporary confusion that can happen during a hospital stay. Despite these limitations, the identification of these specific proteins and pathways offers a new map for understanding the heart-brain connection. By pinpointing the biological mechanisms at play, such as the remodeling of the tissue scaffolding and the response to mechanical stress, this research provides a foundation for future studies that could lead to targeted therapies. The goal is to move beyond treating the heart and the brain as separate problems, and instead develop strategies that address the shared biological roots of their decline.